| Literature DB >> 25153103 |
Marco Aurélio Fornazieri1, Bruno Barros Pinto Borges1, Thiago Freire Pinto Bezerra1, Fábio de Rezende Pinna1, Richard Louis Voegels1.
Abstract
INTRODUCTION: Establishing a diagnosis in patients with olfactory disturbances has always been challenging for physicians.One reason for this is the rarity of some of the diseases that affect this sense, such as Kallmann's syndrome and post-viral olfactory loss.Entities:
Mesh:
Year: 2014 PMID: 25153103 PMCID: PMC9535487 DOI: 10.1016/j.bjorl.2014.02.001
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Anamnesis questions.
| General information: name, age, gender, ethnicity, occupation, monthly income, educational level |
|---|
| Unilateral or bilateral loss? |
| Previous nasal surgeries performed |
| Personal history |
| Smoker or ex-smoker? How many cigarettes a day? |
| Do you have difficulty feeling the taste of things? |
| Current medications |
| Did your loss begin after medication use? |
| Exposure to toxic agents to the olfactory system (aminoglycosides, alcohol, formaldehyde, inhalation drugs, sulfur dioxide, carbon monoxide, acrylates, and methacrylates) |
| Did your loss begin after a cold or the flu? |
| If it begined after a cold or flu, how many days after did it begin? |
| History of head trauma? |
| Did you loose your sense of smell after a trauma to the head? |
| Previous nasal disease diagnosed by a physician? |
| Neurological diseases: Parkinson's, Alzheimer's, epilepsy, stroke, severe memory disorder. |
| Previous treatment of olfactory disorder? |
| Olfactory symptoms followed by seizure? |
| Duration or alteration of olfactory loss |
Examinations performed.
| Type of examination | Indications |
|---|---|
| General: oroscopy, anterior rhinoscopy, otoscopy. | All |
| Nasofibroscopy (focus on the olfactory fossa) | All |
| Alcohol test | All |
| Mini-mental state examination | Patients older than 65 years |
| UPSIT | All |
| Laboratory tests (levels of vitamin B12, TSH, free T4, AST, ALT, GGT, full coagulation test, urea, creatinine, fasting glycemia) | When necessary |
| CT of the paranasal sinuses | Patients with chronic rhinosinusitis and olfactory fossa difficult to be visualized by endoscopy |
| Head MRI | Suspected central nervous system etiology for loss of smell and measure of olfatory bulbs |
Fig. 1Male patient undergoing smell identification test (SIT) with booklet positioned at 1 cm from the nose.
Main established treatments.
| Treatment | Indications | Posology |
|---|---|---|
| Oral corticoid therapy | Rhinosinusitis, idiopathic | prednisolone 40 mg for 7 days, 20 mg for 7 days, and 10 mg for 7 days |
| Budesonide nasal wash | Rhinosinusitis, idiopathic | 0.5 mg of budesonide per day |
| Alpha lipoic acid | Post-viral, idiopathic | 300 mg 2×/day for 1 month |
| Olfactory training with cloves, rose-scented perfume, eucalyptus and lemon. | Post-viral, post-trauma, idiopathic | 10 seconds every substance 2 × day |
Demographic characteristics of the study population.
| Variable | Category | n (%) |
|---|---|---|
| Gender | Male | 31 (50%) |
| Female | 31 (50%) | |
| Age (years) | 44.2 ± 19.4 | |
| Smoking | 8 (13%) | |
| Ethnicity | White | 39 (63%) |
| Non-white | 23 (37%) |
Etiology of olfactory complaints and mean score at the University of Pennsylvania Smell Identification Test (UPSIT).
| Etiology | n | Percentage | Mean UPSIT score | SD |
|---|---|---|---|---|
| Chronic rhinosinusitis with nasal polyps | 11 | 18% | 22 | 9.9 |
| Chronic rhinosinusitis without nasal polyps | 8 | 13% | 26.4 | 6.5 |
| Post-viral infection loss | 8 | 13% | 14.6 | 6.9 |
| Olfactory loss after head trauma | 5 | 8% | 13.8 | 4.6 |
| Rhinitis | 12 | 19% | 27 | 8.1 |
| Other causes | 18 | 29% | 16.7 | 9.8 |
| Total | 62 | 100% | 20.6 | 9.2 |
SD, standard deviation; n, number of patients.
Fig. 2Boxplot of age range of individuals divided by etiology. Chronic rhinosinusitis without (1) and with(2) nasal polyps, post-viral(3), post-trauma(4), rhinitis (5) and other causes (6).